Company profile BTAI
After 39 days of this quarter the interest is at 27.0. Based on that we can calculate that during remaining 52 days it will total up to 63.0. BioXcel Therapeutics expected interest is significantly lower compared to previous quarter (-62.0%) and same quarter last year (-55.6%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 28 | 70 150.0% QoQ | 95 35.7% QoQ | 69 -27.4% QoQ |
| 2020 | 315 1025.0% YoY 356.5% QoQ | 198 182.9% YoY -37.1% QoQ | 290 205.3% YoY 46.5% QoQ | 172 149.3% YoY -40.7% QoQ |
| 2021 | 164 -47.9% YoY -4.7% QoQ | 107 -46.0% YoY -34.8% QoQ | 99 -65.9% YoY -7.5% QoQ | 83 -51.7% YoY -16.2% QoQ |
| 2022 | 133 -18.9% YoY 60.2% QoQ | 173 61.7% YoY 30.1% QoQ | 93 -6.1% YoY -46.2% QoQ | 72 -13.3% YoY -22.6% QoQ |
| 2023 | 142 6.8% YoY 97.2% QoQ | 86 -50.3% YoY -39.4% QoQ | 248 166.7% YoY 188.4% QoQ | 166 130.6% YoY -33.1% QoQ |
| 2024 | 27 -81.0% YoY -83.7% QoQ | - | - | - |
The average 5 years interest of BioXcel Therapeutics was 10.84 per week. The last year interest of BioXcel Therapeutics compared to the last 5 years has changed by 5.35%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 94.55%.
There is not enough data for BioXcel Therapeutics drugs to provide analysis
There is not enough data for BioXcel Therapeutics drugs to provide correlation calculation
There is not enough data for BioXcel Therapeutics drugs to provide analysis
There is not enough data for IGALMI dexmedetomidine to provide analysis
There is not enough data for IGALMI dexmedetomidine to provide correlation calculation
There is not enough data for IGALMI dexmedetomidine to provide analysis
There is not enough data for BioXcel Therapeutics psychiatric disorders to provide analysis
There is not enough data for BioXcel Therapeutics psychiatric disorders to provide correlation calculation
There is not enough data for BioXcel Therapeutics psychiatric disorders to provide analysis
There is not enough data for BXCL501 Alzheimer's disease to provide analysis
There is not enough data for BXCL501 Alzheimer's disease to provide correlation calculation
There is not enough data for BXCL501 Alzheimer's disease to provide analysis
There is not enough data for BXCL501 major depressive disorder to provide analysis
There is not enough data for BXCL501 major depressive disorder to provide correlation calculation
There is not enough data for BXCL501 major depressive disorder to provide analysis
There is not enough data for BXCL501 bipolar disorders to provide analysis
There is not enough data for BXCL501 bipolar disorders to provide correlation calculation
There is not enough data for BXCL501 bipolar disorders to provide analysis
There is not enough data for BXCL502 chronic agitation dementia to provide analysis
There is not enough data for BXCL502 chronic agitation dementia to provide correlation calculation
There is not enough data for BXCL502 chronic agitation dementia to provide analysis
There is not enough data for BioXcel Therapeutics prostate cancer to provide analysis
There is not enough data for BioXcel Therapeutics prostate cancer to provide correlation calculation
There is not enough data for BioXcel Therapeutics prostate cancer to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. BioXcel Therapeutics -stock -company expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 108 | 79 -26.9% QoQ | 137 73.4% QoQ | 67 -51.1% QoQ |
| 2020 | 290 168.5% YoY 332.8% QoQ | 91 15.2% YoY -68.6% QoQ | 227 65.7% YoY 149.5% QoQ | 92 37.3% YoY -59.5% QoQ |
| 2021 | 102 -64.8% YoY 10.9% QoQ | 103 13.2% YoY 1.0% QoQ | 52 -77.1% YoY -49.5% QoQ | 99 7.6% YoY 90.4% QoQ |
| 2022 | 159 55.9% YoY 60.6% QoQ | 147 42.7% YoY -7.5% QoQ | 190 265.4% YoY 29.3% QoQ | 111 12.1% YoY -41.6% QoQ |
| 2023 | 106 -33.3% YoY -4.5% QoQ | 142 -3.4% YoY 34.0% QoQ | 87 -54.2% YoY -38.7% QoQ | 114 2.7% YoY 31.0% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of BioXcel Therapeutics -stock -company was 9.59 per week. The last year interest of BioXcel Therapeutics -stock -company compared to the last 5 years has changed by -24.61%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -12.15%.